Affinity Asset Advisors »

Jatt Ii Acquisition Corp shares owned by Affinity Asset Advisors

Quarter-by-quarter ownership of Jatt Ii Acquisition Corp shares owned by Affinity Asset Advisors from 13F filings

Historical chart of Affinity Asset Advisors investment in Jatt Ii Acquisition Corp

Tip: Access up to 7 years of quarterly data

All positions including Jatt Ii Acquisition Corp held by Affinity Asset Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Jatt Ii Acquisition Corp by Affinity Asset Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.3M 200k 11.36

More positions owned by Affinity Asset Advisors

Roivant Sciences SHS (ROIV)
Apogee Therapeutics (APGE)
Spyre Therapeutics Com New (SYRE)
Xenon Pharmaceuticals (XENE)
Erasca (ERAS)
Alkermes SHS (ALKS)
Insmed Com Par $.01 (INSM)
Moderna Put Option (MRNA)
Praxis Precision Medicines I Com New (PRAX)
Oruka Therapeutics (ORKA)
Anaptysbio Inc Common (ANAB)
Avalo Therapeutics Com New (AVTX)
Cytokinetics Com New (CYTK)
Revolution Medicines (RVMD)
Abivax Sa Sponsored Ads (ABVX)

View all positions for Affinity Asset Advisors

Top funds holding Jatt Ii Acquisition Corp

Affinity Asset Advisors
Spruce Street Capital
Clear Street Group

View all funds holding Jatt Ii Acquisition Corp